Salem Investment Counselors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $353 | Hold |
167
| – | – | ﹤0.01% | 1129 |
|
|
2025
Q1 | $204 | Hold |
167
| – | – | ﹤0.01% | 1180 |
|
|
2024
Q4 | $216 | Hold |
167
| – | – | ﹤0.01% | 1155 |
|
|
2024
Q3 | $460 | Hold |
167
| – | – | ﹤0.01% | 1135 |
|
|
2024
Q2 | $378 | Hold |
167
| – | – | ﹤0.01% | 1120 |
|
|
2024
Q1 | $400 | Hold |
167
| – | – | ﹤0.01% | 1126 |
|
|
2023
Q4 | $278 | Hold |
167
| – | – | ﹤0.01% | 1075 |
|
|
2023
Q3 | $321 | Hold |
167
| – | – | ﹤0.01% | 1059 |
|
|
2023
Q2 | $241 | Hold |
167
| – | – | ﹤0.01% | 1109 |
|
|
2023
Q1 | $351 | Hold |
167
| – | – | ﹤0.01% | 1066 |
|
|
2022
Q4 | $189 | Hold |
167
| – | – | ﹤0.01% | 1051 |
|
|
2022
Q3 | $0 | Hold |
167
| – | – | ﹤0.01% | 1061 |
|
|
2022
Q2 | $0 | Hold |
167
| – | – | ﹤0.01% | 1086 |
|
|
2022
Q1 | $0 | Hold |
167
| – | – | ﹤0.01% | 1034 |
|
|
2021
Q4 | $0 | Hold |
167
| – | – | ﹤0.01% | 1076 |
|
|
2021
Q3 | $1K | Hold |
167
| – | – | ﹤0.01% | 931 |
|
|
2021
Q2 | $1K | Hold |
167
| – | – | ﹤0.01% | 864 |
|
|
2021
Q1 | $0 | Hold |
167
| – | – | ﹤0.01% | 875 |
|
|
2020
Q4 | $0 | Hold |
167
| – | – | ﹤0.01% | 804 |
|
|
2020
Q3 | $0 | Hold |
167
| – | – | ﹤0.01% | 707 |
|
|
2020
Q2 | $1K | Hold |
167
| – | – | ﹤0.01% | 670 |
|
|
2020
Q1 | $0 | Hold |
167
| – | – | ﹤0.01% | 683 |
|
|
2019
Q4 | $0 | Hold |
167
| – | – | ﹤0.01% | 694 |
|
|
2019
Q3 | $1K | Hold |
167
| – | – | ﹤0.01% | 626 |
|
|
2019
Q2 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 649 |
|
|
2018
Q3 | – | Sell |
-167
| Closed | -$1K | – | 472 |
|
|
2018
Q2 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 517 |
|
|
2018
Q1 | – | Sell |
-167
| Closed | -$1K | – | 533 |
|
|
2017
Q4 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 540 |
|
|
2017
Q3 | – | Sell |
-167
| Closed | – | – | 608 |
|
|
2017
Q2 | $0 | Buy |
+167
| New | – | ﹤0.01% | 682 |
|